GI Pharm Flashcards

1
Q

cytoprotectants

A
  • bismuth subsalicylate
  • sucralfate
  • misoprostol (protect from NSAIDs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antacids

A
  • aluminum hydroxide
  • magnesium hydroxide
  • calcium carbonate
  • sodium bicarbonate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

H2-receptor antagonists

A
  • cimetidine
  • ranitidine
  • famotidine
  • nizatidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PPIs

A
Omeprazole 
Lansoprazole
Rabeprazole
Pantoprazole
Esomeprazole
Dexlansoprazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

antacids AE

A
  • diarrhea
  • constipation
  • abd distension

cautions: kidney insufficiency, drug interactions (chelation w/ fluoroquinolone, tetracyclines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

antacids MOA

A

work locally within the GI lumen to neutralize acid

quick relief of symptoms, but duration of action short (a few hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bismuth compounds

A
  • bind to base of ulcers
  • promote mucin and bicarb production
  • antibacterial effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bismuth subsalicylate

AE

A

(pepto-bismol)

  • constipation
  • darkening of of tongue/stool
  • avoid if aspirin allergy
  • drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

sucralfate

A

sulfated polysaccharide + AlOH3

  • drug (-) pref binds damaged GI mucosa (+)
  • activ by acidic envio
  • lasts up to 6 hr
  • low bioavailability

uses: acid-peptic ulcer disease (adjunctive or alt agent), stress ulcer prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sucralfate AE

A
  • constipation*
  • accumulation to Al3+
  • drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

sucralfate use in kidney insufficiency is dangerous why

A

accumulation of Al 3+ can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

misoprostol

A

prostaglandin E analog

  • stim secretion of mucin and bicarb
  • inc mucosal BF
  • suppresses acid production in parietal cell by binding to EP3 receptor

PROTECT FROM NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

misoprostol

AE

A
  • diarrhea

- inc uterine contractility (termination/induction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

H2 antagonists

A
  • compete w/ histamine for binding to H2 receptors on parietal cells
  • more potent, longer-lasting effects than traditional antacids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

H2 antagonist uses

A
  • uncomplicated GERD
  • gastric and duodenal ulcers
  • stress ulcer prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

H2A should be dose adjusted for

A

kidney insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

H2A adverse effects

A
  • diarrhea
  • constipation
  • drowsiness
  • fatigue
  • HA
  • BM suppression (rare)
  • drug interactions (changes pH, interferes w/ drugs req acidic envio)
  • CNS w/ high doses (confusion, delirium, hallucinations/slurred speech)
  • cimetidine (gynecomastia/galactorrhea)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

gynecomastia (men)

galactorrhea (women)

A

cimetidine (H2A)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

H2A drug interactions

A

drugs req an acidic environment (atazanavir, itraconazole)

cimetidine (H2A) =inhibitor of CYP-450 (phenytoin, theophylline, warfarin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PPI

MOA

A

IRREVERSIBLY bind to and inactivate H/K-ATPASE

  • prodrugs, req activation in acidic envio
  • parent cpd=unstable in acid
  • enteric coated formulations usu req
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PPI

pharmacokinetics

A

plasma half life 1-2hr

onset 2-4 days

duration of effect 24-48 hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PPI

uses

A
  • gastric and duodenal ulcers
  • GERF
  • Barret’s esophagus
  • Zollinger-Ellison syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PPI

AE

A
  • nausea, diarrhea, abd pain, constipation
  • altered B12/Ca/Mg absorption
  • rash, myopathy, arthralgia, HA
  • ECL hyperplasia
  • infec, fractures?
24
Q

anti-platelet + PPI = interaction?

A

clopidogrel (prodrug) –> active form includes 2 steps req p450 enz (2C19) which is inhibited by PPI

25
H. pylori tx
multiple antimicrobials + high dose acid suppressive therapy ``` "triple therapy" exp. -clarithromycin -amoxicillin -PPI ``` tx duration=10-14d of abx, then continue PPI 2 more wks at lower dose AE: nausea, diarrhea, taste disturb, allergic rxn
26
prokinetic for constipation cholinergic agents
bethanchol
27
prokinetic for constipation serotonin receptor modulators
metoclopramide | cisapride
28
prokinetic for constipation DA receptor modulators
metoclopramide | domperidone
29
prokinetic for constipation motilin-like agents
erythromycin
30
black box warning of metoclopramide
extrapyramidal symptoms (tardive dyskinesia, parkinsonian type features)
31
bulk-forming agents for constipation MOA
not absorbed systemically MOA: source of fiber enhances stool mass
32
bulk-forming agents for constipation AE
- bloating/abd pain (AVOID if suspect obstruction) | - drug interactions
33
bulk-forming agents for constipation (natural)
psyllium
34
bulk-forming agents for constipation (semi-synthetic)
methylcellulose | polycarbophil
35
softeners/surfactants MOA
lowers surface tension of stool
36
softeners/surfactants | AE
- impaired absorption of fat soluble agents - oil leakage - lipid pneumonitis
37
softeners/surfactants exp
decussate | mineral oil
38
osmotic agents for constipation MOA
osmotically-mediated water retention stimulates peristalsis
39
osmotic agents for constipation AE
abd discomfort flatulence caution w/saline based osmotic agents if CVD disease present
40
osmotic agents for constipation | saline-based
Mg citrate | Phosphate salts
41
osmotic agents for constipation | sugar/alcohol-based
- lactulose, sorbitol, mannitol | - glycerin (suppositories/enemas)
42
osmotic agents for constipation | other
polyethylene glycol solutions
43
stimulant laxatives | MOA
produce migrating colonic contractions
44
stimulant for constipation concerns/toxicities
- avoid overuse | - phenolphthalei/danthron-containing products banned
45
stimulant for constipation exps
- diphenylmethanes (bisacodyl) - anthraquinones (aloe, cascara, SENNA) - castor oil
46
Senna is a
stimulant laxative
47
guanylate cyclase agonists 2 actions
1. suppress afferent pain fibers | 2. activate CTFR (inc GI secretion)
48
5HT4 receptor agonists for constipation
- tegaserod (IBS, F>40y/o) - prucalopride inc serotonin, promotes motility
49
peripherally acting mu-opioid receptor antagonists for constipation
- methylnaltrexone - naloxegol - alvimopan - naldemedine
50
bulk-forming agents used for diarrhea
- bismuth subsalicylate | - cholestyramine
51
anti motility agents for diarrhea opioid derivatives
- loperamide - diphenoxylate + atropine - eluxadoline slow intestinal transit by binding as agonists at opioid receptors thru GI tract
52
alosetron
5HT3 receptor antagonist - for women - when primary sx=diarrhea - AE: potential for severe GI side effects
53
RIfaximin
rifampin-derived antibiotic | -precise MOA unclear, poss changes in bacterial content
54
octreotide
- peptide analog of naturally occurring SST that inhibits secretion of serotonin/gastrin/VIP/insulin - splanchnic VASOCONSTRICTION use: secretory diarrhea, variceal bleeding parenteral route AE: nausea, bloating, injection site reactions
55
Clonidine
◦ A centrally acting alpha-2 receptor agonist that reduces sympathetic outjow. ◦ Side effects include hypotension and rebound hypertension if abruptly discontinued. ◦ Other side effects include sedation and dry mouth.
56
type 2 chloride channel agonists
activates chloride channels within GI tract increasing intestinal fluid secretion exp. Lubiprostone